Answers are grounded in this paper and cite their sources.
This research compares semaglutide treatment effects on body composition and energy expenditure in obese minipigs, suggesting potential benefits for obesity management.
Objective: To compare the effects of diet restriction and semaglutide treatment on body composition (BC), energy expenditure (EE), and metabolic adaptation (MA) in Göttingen Minipigs as a model for human obesity. Methods: Diet-induced obese Göttingen Minipigs were divided into three groups (n=8): a control group receiving vehicle and fed ad libitum, a group treated with the GLP-1 receptor agonist (GLP-1RA) semaglutide and fed ad libitum, and a diet-restricted group receiving vehicle and weight-matched the semaglutide group. BC, EE, and plasma parameters were measured at baseline and after 10 weeks; tissue mitochondrial respiration and myosin conformation were measured after 10 weeks. Results: Diet-restricted minipigs gained 6.8 % (p<0.01) more body fat compared to semaglutide, mediated by a greater loss of fat-free mass (4.3 kg, p<0.05) and a tendency for a higher fat mass gain (p=ns). Diet restriction led to significantly decreased EE compared to the control group (-273 kcal/day, p<0.05), but no differences between groups were observed when adjusting EE for changes in BC. Energy balance modeling revealed significant MA in the diet-restricted animals (p<0.01) compared to both control and semaglutide groups. Diet restriction was further associated with decreased proton leak and resting myosin ATP consumption in muscle. Conclusions: Semaglutide treatment improved BC and EE outcomes compared to diet restriction despite similar weight trajectories. Furthermore, semaglutide treatment prevented specific energy-conserving changes in tissues, thus highlighting novel mechanisms regulating energy balance during GLP-1RA treatment.
No takes yet. Share an insight, caveat, or question.
Bredum et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: